Oxaloacetate CFS – 90 Capsules, 500mg " with an average fatigue

" with an average fatigue reduction of 63%

No fillers

Full policy details here

Improvements in both mental and physical fatigue markers

Active Ingredient

Oxaloacetate CFS – 90 Capsules, 500mg " with an average fatigueClinically Proven to Significantly Reduce Physical and Mental Fatigue in ME CFS and Long COVID Patients Anhydrous Enol Oxaloacetate (AEO), 500 mg Capsules, 90 count Bottle Peer Reviewed Clinical Trials Frontiers In Neurology: A significant reduction of fatigue by an average of 25 to 35% Improvements in both mental and physical fatigue markers 40. 5% of patients given oxaloacetate are classified as "enhanced responders," with an average fatigue